Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
D-dimer Testing
... at a CAGR of 4.0% over the analysis period 2023-2030. D-dimer Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$1.3 Billion by ... Read More
-
Hemostasis Diagnostics
... at a CAGR of 4.8% over the analysis period 2023-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the ... Read More
-
Hemostasis Products
... at a CAGR of 3.8% over the analysis period 2023-2030. Infusible Hemostasis Products, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end ... Read More
-
IVD Test Procedure Volumes, 2024-2029
... in The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition, this essential report delivers actionable data on the growth, challenges, and emerging opportunities in the IVD space. As a rapidly evolving market, the ... Read More
-
2024-2028 Antithrombin II Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Fibrinogen Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, ... Read More
-
2024-2028 Global Antithrombin II Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
2024-2028 D-Dimer Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, ... Read More
-
2024-2028 Heparin/Anti-Factor Xa Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Factor Assays Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
Hemostasis and Tissue Sealing Agents
... is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Topical Hemostat, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Heparin
... of 2.8% over the analysis period 2023-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.1% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$8.8 Billion by the ... Read More
-
Coagulation Testing
... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
-
30-Country IVD Market
... Changes Over 2800 Data Points Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic ... Read More
-
2024 Coagulation Testing Market: Emerging Technologies and Strategic Profiles of Leading Suppliers
... coagulation testing. The report also includes strategic assessments of current and emerging suppliers of coagulation instruments and reagents, products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Please note: ... Read More
-
2024 Coagulation Analyzers and Strategic Profiles of Leading Suppliers
... of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Please note: The delivery time for the electronic version of this report is between 1-3 business days to ... Read More
-
2024 POC and Laboratory Coagulation Testing Markets: Sales Forecasts by Country, Strategic Profiles of Leading Suppliers
... coagulation tests, test volume and sales forecasts for coagulation reagents and instruments by country, and major suppliers'; sales and market shares. The report also provides worldwide test volume estimates for 38 coagulation assays. The report ... Read More
-
2024 Emerging Coagulation Tests and Strategic Profiles of Leading Suppliers
... coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Please note: The ... Read More
-
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Hematology, Coagulation, Microbiology), By Application, By Country, And Segment Forecasts, 2024 - 203
... 2030 U.S. IVD And LDT For Autoimmune Diseases Market Growth & Trends The U.S. IVD and LDT for autoimmune diseases market size is expected to reach USD 3.70 billion by 2030, growing at a CAGR ... Read More
-
Africa IVD Market Size, Share, Forecast, & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation) Application (Infectious Diseases, Diabetes, Oncology) Diagnostic Approach (Lab, OTC, PoCT) End User- Forecast to 2031
... market is expected to reach $1.65 billion by 2031, at a CAGR of 3.1% from 2024 to 2031. With extensive primary and secondary research and in-depth analysis of the market scenario, the report studies the ... Read More
-
Global Four Channel Fully Automated Coagulation Analyzer Market Growth 2024-2030
... to perform coagulation tests automatically on multiple samples simultaneously. It can handle up to four channels, allowing for high throughput testing. The global Four Channel Fully Automated Coagulation Analyzer market size is projected to grow ... Read More
Research Assistance
